DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/bxl5pl/investigation) has announced the addition of the "Investigation Report on China's ribonucleic acid II (RNAII) for Injection, 2010-2019" report to their offering. RNAII for injection, one kind of immunomodulator, can improve body immunity and inhibit tumor by causing vacuolar degeneration and colliquative necrosis in tumor cells as well as generating large amounts of hyperplastic fibroblasts, macroph